Form D — DalCor Pharmaceuticals US, LLC
0001231919-26-001113 · filed Aug 28, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $6,958,236
- Reported amount sold
- $6,958,236
- Minimum investment
- $0
- Investors
- 8
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- DalCor Pharmaceuticals US, LLC
- CIK
- 1673368
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 677 North Washington Blvd
Sarasota, FL 34236 - Phone
- 514 508-5099
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Douglas Michael Dixon · DirectorSarasota, FL Find on LinkedIn ↗
-
Paul Fonteyne · DirectorSarasota, FL Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗